Skip to content
10-Q

Quarterly Report

CELLULAR BIOMEDICINE GROUP, INC.

0001654954-20-008950

← back to feed
Filed
Aug 12, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 1, 2020 19.43M sh
Shares Diluted Q2 2020 · Jun 30, 2020 19.4M sh
Shares Diluted Q2 2020 · Jun 30, 2020 19.37M sh
Shares Diluted Q2 2020 · Jun 30, 2019 19.22M sh
Shares Diluted Q2 2020 · Jun 30, 2019 18.69M sh
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$19.82M
Operating Cash Flow restated Q2 2020 · Jun 30, 2019 −$18.8M
Short Term Debt Q2 2020 · Jun 30, 2020 $19.47M
Short Term Debt Q2 2020 · Dec 31, 2019 $14.33M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $13.58M
Stockholders Equity Q2 2020 · Jun 30, 2020 $32.53M
Stockholders Equity Q2 2020 · Mar 31, 2020 $45.15M
Stockholders Equity Q2 2020 · Dec 31, 2019 $55.72M
Stockholders Equity Q2 2020 · Jun 30, 2019 $82.18M
Stockholders Equity Q2 2020 · Mar 31, 2019 $92.51M
Stockholders Equity Q2 2020 · Dec 31, 2018 $85.22M
Current Liabilities Q2 2020 · Jun 30, 2020 $28.45M
Current Liabilities Q2 2020 · Dec 31, 2019 $23.67M
Total Liabilities Q2 2020 · Jun 30, 2020 $45.04M
Total Liabilities Q2 2020 · Dec 31, 2019 $41.61M
Current Assets Q2 2020 · Jun 30, 2020 $14.98M
Current Assets Q2 2020 · Dec 31, 2019 $34.03M
Total Assets Q2 2020 · Jun 30, 2020 $77.57M
Total Assets Q2 2020 · Dec 31, 2019 $97.32M
Sga Expense Q2 2020 · Jun 30, 2020 $3.28M
Sga Expense Q2 2020 · Jun 30, 2020 $6.71M
Sga Expense Q2 2020 · Jun 30, 2019 $3.18M
Sga Expense Q2 2020 · Jun 30, 2019 $6.63M
Rd Expense Q2 2020 · Jun 30, 2020 $10.09M
Rd Expense Q2 2020 · Jun 30, 2020 $17.85M
Rd Expense Q2 2020 · Jun 30, 2019 $9.06M
Rd Expense Q2 2020 · Jun 30, 2019 $15.03M
Net Income Q2 2020 · Jun 30, 2020 −$13.53M
Net Income Q2 2020 · Jun 30, 2020 −$25.08M
Net Income Q2 2020 · Jun 30, 2019 −$12.1M
Net Income Q2 2020 · Jun 30, 2019 −$21.43M
Operating Income Q2 2020 · Jun 30, 2020 −$13.37M
Operating Income Q2 2020 · Jun 30, 2020 −$24.8M
Operating Income Q2 2020 · Jun 30, 2019 −$12.28M
Operating Income Q2 2020 · Jun 30, 2019 −$21.7M
Cost Of Revenue Q2 2020 · Jun 30, 2020 $0
Cost Of Revenue Q2 2020 · Jun 30, 2019 $8.09K
Revenue Q2 2020 · Jun 30, 2020 $0
Revenue Q2 2020 · Jun 30, 2020 $0
Revenue Q2 2020 · Jun 30, 2019 $0
Revenue Q2 2020 · Jun 30, 2019 $49.27K